Vaccination with human induced pluripotent stem cells creates an antigen-specific immune response against HIV-1 gp160

Frontiers in Microbiology

Volumn 2, Issue FEB, 2011, Pages

  Yoshizaki, Shinji ^a   Nishi, Mayuko ^a   Kondo, Asami ^a   Kojima, Yoshitsugu ^a   Yamamoto, Naoki ^b   Ryo, Akihide ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cellular immunity; Human induced pluripotent stem cells; Ionizing radiation; Pro inflammatory cytokine; Vaccine

Indexed keywords

EID: 84862834895     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00027     Document Type: Article

References (29)

1. Abe, S., Okuda, K., Ura, T., Kondo, A., Yoshida, A., Yoshizaki, S., Mizuguchi, H., Klinman, D., and Shimada, M. (2009). Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5. J. Gene Med. 11, 570-579.
2. Ardeshna, K. M., Pizzey, A. R., Devereux, S., and Khwaja, A. (2000). The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96, 1039-1046.
3. Guo, Y., Graham-Evans, B., and Broxmeyer, H. E. (2006). Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells. Stem Cells 24, 850-856.
4. Hall, B. M., Robinson, C. M., Plain, K. M., Verma, N. D., Carter, N., Boyd, R. A., Tran, G. T., and Hodgkinson, S. J. (2008). Studies on naive CD4 + CD25 + T cells inhibition of naive CD4 + CD25 - T cells in mixed lymphocyte cultures. Transpl. Immunol. 18, 291-301.
5. Hovav, A. H., Cayabyab, M. J., Panas, M. W., Santra, S., Greenland, J., Geiben, R., Haynes, B. F., Jacobs, W. R. Jr., and Letvin, N. L. (2007). Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis. J. Virol. 81, 74-83.
6. Kidd, P. (2003). Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8, 223-246.
7. Kong, J., and Li, Y. C. (2002). Upregulation of interleukin-18 expression in mouse primary keratinocytes induced to differentiate by calcium. Arch. Dermatol. Res. 294, 370-376.
8. Li, B., Simmons, A., Du, T., Lin, C., Moskalenko, M., Gonzalez-Edick, M., VanRoey, M., and Jooss, K. (2009a). Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Clin. Immunol. 133, 184-197.
9. Li, Y., Zeng, H., Xu, R. H., Liu, B., and Li, Z. (2009b). Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer. Stem Cells 27, 3103-3111.
10. Libert, C., Brouckaert, P., Shaw, A., and Fiers, W. (1990). Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Eur. J. Immunol. 20, 691-694.
11. Lieber, A., He, C. Y., Kirillova, I., and Kay, M. A. (1996). Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70, 8944-8960.
12. Maitra, B., Szekely, E., Gjini, K., Laughlin, M. J., Dennis, J., Haynesworth, S. E., and Koc, O. N. (2004). Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33, 597-604.
13. McElrath, M. J., and Haynes, B. F. (2010). Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33, 542-554.
14. Mizuguchi, H., and Kay, M. A. (1998). Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9, 2577-2583.
15. Morrison, S. J., and Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441, 1068-1074.
16. Park, I. H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., and Daley, G. Q. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146.
17. Schoenhaut, D. S., Chua, A. O., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., McComas, W., Familletti, P. C., Gately, M. K., and Gubler, U. (1992). Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
18. Senju, S., Haruta, M., Matsunaga, Y., Fukushima, S., Ikeda, T., Takahashi, K., Okita, K., Yamanaka, S., and Nishimura, Y. (2009). Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 27, 1021-1031.
19. Shimada, M., Yoshizaki, S., Jounai, N., Kondo, A., Ichino, M., Ryo, A., and Okuda, K. (2010). DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity. Vaccine 28, 4920-4927.
20. Suarez-Alvarez, B., Rodriguez, R. M., Calvanese, V., Blanco-Gelaz, M. A., Suhr, S. T., Ortega, F., Otero, J., Cibelli, J. B., Moore, H., Fraga, M. F., and Lopez-Larrea, C. (2010). Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS ONE 5, e10192. doi: 10.1371/journal.pone.0010192
21. Takahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghten, R., Cornette, J. L., DeLisi, C., Moss, B., Germain, R. N., and Berzofsky, J. A. (1988). An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 85, 3105-3109.
22. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
23. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
24. Tashiro, K., Kawabata, K., Inamura, M., Takayama, K., Furukawa, N., Sakurai, F., Katayama, K., Hayakawa, T., Furue, M. K., and Mizuguchi, H. (2010). Adenovirus vector-mediated efficient transduction into human embryonic and induced pluripotent stem cells. Cell. Reprogram. 12, 501-507.
25. Villacres, M. C., Zuo, J., and Bergmann, C. C. (2000). Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses. Virology 270, 54-64.
26. Weber, A., Wasiliew, P., and Kracht, M. (2010). Interleukin-1 (IL-1) pathway. Sci. Signal. 3, cm1.
27. Yamamoto, H., and Matano, T. (2008). Anti-HIV adaptive immunity: determinants for viral persistence. Rev. Med. Virol. 18, 293-303.
28. Yoon, T. J., Kim, J. Y., Kim, H., Hong, C., Lee, H., Lee, C. K., Lee, K. H., Hong, S., and Park, S. H. (2008). Anti-tumor immunostimulatory effect of heat-killed tumor cells. Exp. Mol. Med. 40, 130-144.
29. Yoshimura, S., Bondeson, J., Brennan, F. M., Foxwell, B. M., and Feldmann, M. (2003). Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo. Scand. J. Immunol. 58, 165-172.